DRTS: Alpha Tau Medical Ltd. - Summary | Jitta

Alpha Tau Medical Ltd.

NASDAQ:DRTS

Price
$10.04
Loss Chance
59.1%
n/aJITTA SCORE
100.00%Over Jitta Line
Jitta Ranking
Sorry, the data is not yet available for this stock.
HISTORICAL JITTA SCORE
Sorry, the data is not yet available for this stock.
Jitta Factors
Growth Opportunity (3)
Recent Business Performance (17)
Financial Strength (40)
Return to Shareholders (0)
Competitive Advantage (3)
Jitta Signs
Cash Conversion CycleLess than 30 days
Recent Business PerformanceEarning decline 107.97% in the last quarter (yoy)
New Share IssuedMore than 50% in 5 years
CapExVery High
Key Stats
Jitta Score
Jitta Line
n/a
100.00%
3.06
206.98%
Health Care Equipment
5.75
0.43%
7.38
7.79%
7.50
4.33%
COMPANY DESCRIPTION
Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer. Its Alpha-DaRT technology is in clinical trials for various forms comprising skin, oral, pancreatic, prostate, lung, liver, and breast cancers; and preclinical clinical studies for mouse tumors and human-derived tumors. The company is headquartered in Jerusalem, Israel.